Compounds in garlic fight malaria and cancer

November 13, 2001

A group of compounds commonly found in garlic may not only an effective treatment for malaria, the mechanism by which they inhibit the infection appears to be similar to the mechanism they use to fight cancer cells.

Researchers from the University of Toronto report these findings today at the 50th Annual Meeting of the American Society of Tropical Medicine and Hygiene in Atlanta.

"Does eating garlic influence the outcome of malaria? There is evidence that yes, it may," says Ian Crandall, Assistant Professor of Laboratory Medicine and Pathobiology at the University of Toronto, who presented the study.

The compounds, called disulfides, occur naturally in garlic, onions and mahogany trees and are known to have antifungal, anticancer and antibacterial properties.

For years scientists have suspected that one of these compounds in garlic may be helpful against malaria and have proven it in animal models.

Crandall and his colleagues, though, were more interested in understanding how these disulfides worked against infection.

They tested 11 different synthetic disulfide compounds against malaria-infected cells. They also tested the effect of these compounds on cancer cells. While not all of the disulfides were effective against Plasmodium falciparum, the malaria parasite, those that were were also effective at killing the cancer cells.

"We looked at the active compounds to see what they had in common. Apparently P. falciparum-infected cells and these cancer cells seem to have the same susceptibility profile," says Crandall.

Crandall believes that the mechanism of action may be on the glutathione system within the cell. In this system, the glutathione is reduced (the opposite of oxidation) and stored in the cell like energy in a battery. This reduced glutathione can then be brought out to absorb damage caused by oxygen and other harmful particles when needed.

The glutathione system is of particular importance in cells that rapidly reproduce, like cancer cells or malaria-infected cells, because these harmful particles are natural by-products of metabolism.

Ajoene, the disulfide that naturally occurs in garlic, is a known inhibitor of glutathione reduction. "Normal cells recharge glutathione and therefore are able to deal with the oxidative stress that normal metabolism generates, but in the presence of an inhibitor they cannot recharge and therefore are more prone damage and eventually death," says Crandall.

Crandall hopes that one days these compounds may be used to treat not only malaria, but some types of cancer as well. There is one drawback, though. "Does this stuff smell like garlic? Well, every time we open a vial of it in the lab everybody runs."
-end-
Additional releases and a tipsheet for the ASTMH meeting can be found in the online press kit at http://www.astmh.org/meetings/presskit/press.html

American Society for Microbiology

Related Cancer Articles from Brightsurf:

New blood cancer treatment works by selectively interfering with cancer cell signalling
University of Alberta scientists have identified the mechanism of action behind a new type of precision cancer drug for blood cancers that is set for human trials, according to research published in Nature Communications.

UCI researchers uncover cancer cell vulnerabilities; may lead to better cancer therapies
A new University of California, Irvine-led study reveals a protein responsible for genetic changes resulting in a variety of cancers, may also be the key to more effective, targeted cancer therapy.

Breast cancer treatment costs highest among young women with metastic cancer
In a fight for their lives, young women, age 18-44, spend double the amount of older women to survive metastatic breast cancer, according to a large statewide study by the University of North Carolina at Chapel Hill.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.

More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.

New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.

American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.

Read More: Cancer News and Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.